Pharma Nord

Organisation

Trials

  • NCT07234422

    Collaborator, Phase 3, Recruiting, 1,100 people, 18 Nov 2025

  • NCT04960215

    Collaborator, Phase 2, Completed, 121 people, 13 Jul 2021

  • NCT04579640

    Collaborator, Phase 3, Completed, 6,200 people, 8 Oct 2020

  • NCT02451293

    Collaborator, Phase 2/3, Completed, 252 people, 21 May 2015

  • NCT01355523

    Collaborator, Phase 2/3, Terminated, 54 people, 18 May 2011

Named in competing interests

Sources: pubmed.ncbi.nlm.nih.gov